143 related articles for article (PubMed ID: 8514455)
1. Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.
Wölfel T; Herr W; Coulie P; Schmitt U; Meyer zum Büschenfelde KH; Knuth A
Int J Cancer; 1993 Jun; 54(4):636-44. PubMed ID: 8514455
[TBL] [Abstract][Full Text] [Related]
2. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL
Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma.
Ueda D; Sato N; Matsuura A; Sasaki A; Takahashi S; Ikeda H; Wada Y; Kikuchi K
Jpn J Cancer Res; 1995 Jul; 86(7):691-7. PubMed ID: 7559088
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
[TBL] [Abstract][Full Text] [Related]
6. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
7. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
8. [Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes].
Peiper M; Goedegebuure PS; Eberlein TJ; Broelsch CE
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):59-62. PubMed ID: 14518213
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.
Mazzocchi A; Anichini A; Castelli C; Sensi M; Poli F; Russo C; Parmiani G
Cancer Immunol Immunother; 1990; 32(1):13-21. PubMed ID: 2149669
[TBL] [Abstract][Full Text] [Related]
10. Recognition of keratinocytes by cytotoxic T cells specific for conventional HLA class-I alloantigen.
Symington FW; Santos EB
J Invest Dermatol; 1990 Aug; 95(2):224-8. PubMed ID: 2116484
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596
[TBL] [Abstract][Full Text] [Related]
12. Human cytotoxic lymphocytes reactive with pancreatic adenocarcinoma cells.
Wahab ZA; Metzgar RS
Pancreas; 1991 May; 6(3):307-17. PubMed ID: 1862066
[TBL] [Abstract][Full Text] [Related]
13. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte mediated recognition of human pancreatic cancer cells.
Peiper M; Sato T; Streichert T; Eisenberger CF; Knoefel WT; Izbicki JR
Int J Cancer; 2002 May; 99(1):88-92. PubMed ID: 11948497
[TBL] [Abstract][Full Text] [Related]
15. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.
Nisticò P; De Berardinis P; Morrone S; Alonzi T; Buono C; Venturo I; Natali PG
J Clin Invest; 1994 Oct; 94(4):1426-31. PubMed ID: 7929817
[TBL] [Abstract][Full Text] [Related]
17. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.
LeMay LG; Kan-Mitchell J; Goedegebuure P; Harel W; Mitchell MS
Cancer Immunol Immunother; 1993 Aug; 37(3):187-94. PubMed ID: 8101473
[TBL] [Abstract][Full Text] [Related]
18. TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients.
Maccalli C; Farina C; Sensi M; Parmiani G; Anichini A
J Immunol; 1997 Jun; 158(12):5902-13. PubMed ID: 9190943
[TBL] [Abstract][Full Text] [Related]
19. Evidence for cytotoxic T lymphocyte response against human lung cancer: reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I.
Calhoun RF; Naziruddin B; Enriquez-Rincon F; Duffy BF; Ritter JM; Sundaresan S; Patterson GA; Cooper JD; Mohanakumar T
Surgery; 2000 Jul; 128(1):76-85. PubMed ID: 10876189
[TBL] [Abstract][Full Text] [Related]
20. CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells.
Somasundaram R; Robbins P; Moonka D; Loh E; Marincola F; Patel A; Guerry D; Herlyn D
Int J Cancer; 2000 Jan; 85(2):253-9. PubMed ID: 10629086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]